KINASE INHIBITORS, PRODRUG FORMS THEREOF AND THEIR USE IN THERAPY

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising kinase inhibitors or prodrugs, and the use of the compositions for treating cancer.SOLUTION: The present invention provides kinase inhibitors represented by formula I or pharmaceutically acceptable salts or solvates thereof. Als...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KENDALL MARIE CARLIN, ADAM VORN PATTERSON, DENNY WILLIAM ALEXANDER, HSU HUAI-LING, AMIR ASHOORZADEH, ANDREJ MAROZ, LEE HO HUAT, ROBERT FORBES ANDERSON, WILSON WILLIAM ROBERT, LU GUO-LIANG, ALEXANDRA MARIE MOWDAY, JEFFREY BRUCE SMAILL, STEPHEN MICHAEL FRAZER JAMIESON
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide pharmaceutical compositions comprising kinase inhibitors or prodrugs, and the use of the compositions for treating cancer.SOLUTION: The present invention provides kinase inhibitors represented by formula I or pharmaceutically acceptable salts or solvates thereof. Also provided are reductive prodrugs, comprising the kinase inhibitors and reductive triggers linked directly or indirectly to nitrogen of the kinase inhibitors. [Ris H; and Ris (3-chlorobenzyl)oxy and Ris Cl, or Rand Rtogether form 1-(3-fluorobenzyl)-1H-pyrazole, or the like]SELECTED DRAWING: None 【課題】キナーゼインヒビターまたはプロドラッグを含む薬学的組成物、癌を治療するための該組成物の使用の提供。【解決手段】式Iで表されるキナーゼインヒビター、或いはその薬学的に許容される塩または溶媒和物。該キナーゼインヒビターと、このキナーゼインヒビターの窒素に対して直接または間接的に連結された還元性トリガーとを含む、還元性プロドラッグ。[R1はH;R2は(3−クロロベンジル)オキシでR3はCl又はR2及びR3は一緒に1−(3−フルオロベンジル)−1Hピラゾール形成等]【選択図】なし